Cerebrospinal fluid as liquid biopsy for characterizing & policing of medulloblastoma

(Vall d'Hebron Institute of Oncology) Building on previous research led by Joan Seoane, Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor, latest findings from a proof-of-concept study published inNature Communications, show that the analysis of cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA), allows for the more precise characterization, molecular diagnosis (including subtyping and risk stratification), and real time tracking of medulloblastoma (MB) - the most prevalent malignant brain tumor in childhood.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news